High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis

Abstract

High-throughput metabolite quantification, with new systemic biomarkers, improved risk stratification for subclinical atherosclerosis in comparison to conventional lipids and could potentially be useful for early cardiovascular risk assessment.